In 2010 and 2015, the FDA released a pair of draft guidance documents on Adaptive Design clinical trials for drugs and medical devices, which suggests—despite a long history of sticking to an option they trust—that they might at last be willing to explore alternatives.
Authorization is only required to store your personal settings and favorites.
Log in with:
Use this code for embedding the Quote anywhere
